What Virtual Therapeutics does

Virtual Therapeutics Corp. (operating as VThera) is a Kirkland, Washington-based digital therapeutics company developing immersive VR and video-game-based mental health treatments. The company's product portfolio includes EndeavorRX, the only FDA 510(k)-cleared prescription video game treatment for pediatric ADHD; EndeavorOTC, the only FDA-authorized over-the-counter digital therapeutic for adult ADHD; and the Breakthrough mental fitness platform, which bundles Bloom (a VR meditation experience), Happy Happy (attention training), Travel-to (cognitive enhancement through virtual travel), and Sights & Sounds (curiosity activation). Core technology relies on real-time adaptive gameplay algorithms that adjust difficulty per user performance to engage brain networks regulating attention and impulse control, with AI-based analysis providing real-time feedback in the Breakthrough suite. All VR products are delivered through Meta Quest headsets.

The company pursues a hybrid go-to-market model combining direct-to-consumer mobile app sales (EndeavorOTC/RX via Apple App Store and Google Play) with enterprise B2B sales of VR solutions — including preloaded headset shipments — to large healthcare systems, employers, schools, and government agencies. Evidence of demand comes from clinical studies (44.2% of participants achieving clinically meaningful attention improvements in the GAMES Study; 68% of parents reporting ADHD-impairment improvement; 0% serious adverse events) and event-driven demand generation (e.g., 2024 VA Immersive Summit). Revenue streams include hardware sales, subscription/licensing for enterprise deployments, and app-based monetization. Pricing is quote-based and not publicly disclosed.

In May 2024, Virtual Therapeutics signed a definitive merger agreement with Akili, Inc. (Nasdaq: AKLI), and completed the acquisition in August 2024 for $34 million, absorbing Akili's FDA-authorized ADHD digital therapeutics. The company has since integrated with the Meta Quest ecosystem (announced September 2025), expanded government channel access through the VA, and maintains a small team of 11–50 employees. Ownership and investor structure are not disclosed in available sources.

Name

Virtual Therapeutics

Legal name

Virtual Therapeutics Corp.

Website

https://vthera.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Virtual Therapeutics is a Kirkland, Washington-based digital therapeutics company that develops FDA-authorized VR and video-game-based mental health treatments, including EndeavorRX and EndeavorOTC for ADHD, sold to consumers, healthcare systems, employers, schools, and government agencies via Meta Quest and mobile apps.

Ownership category

akta.pro rank

Product category

Digital Therapeutics

NAICS

Offices of Mental Health Practitioners (except Physicians) (621330)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)

akta.pro secondary industries

Pediatrics & Adolescent Therapeutics (Digital) (HLACANAL), VR/AR Gaming Platforms (BPAMAKAG), VR-Based Skills Training Simulations (Soft Skills, Customer Service, Leadership) (EDAFAJAA)

Keywords

• Digital therapeutics
• VR mental health
• ADHD treatment
• Cognitive medicine
• Mental fitness

Headquarters

HQ city

Kirkland

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations

Revenue model

1. Digital Therapeutic Products: Revenue from FDA-authorized digital therapeutic products including EndeavorOTC (OTC) and EndeavorRX (prescription) for ADHD treatment, sold as video-game-based treatments with real-time adaptive features.
2. VR Hardware with Preloaded Software: VR headsets sold with preloaded mental fitness applications (Bloom, Happy Happy, Travel-to, Sights & Sounds) shipped directly to businesses, homes, or offices, combining hardware sales with bundled software.
3. Healthcare/Enterprise Licensing: Licensing of VR mental fitness solutions to large healthcare systems, businesses, schools, and families with reporting platforms for clinicians and employers to validate adoption and track efficacy.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Virtual Therapeutics develops FDA-authorized digital therapeutics and immersive VR experiences for mental health. Its portfolio includes EndeavorRX, the only FDA 510(k)-cleared prescription video game treatment for children with ADHD; EndeavorOTC, the only FDA-authorized over-the-counter digital therapeutic for adult ADHD; and the Breakthrough/Bloom VR mental fitness platform delivered through Meta Quest headsets for clinicians, employers, schools, families, and individuals.

Product overview

Virtual Therapeutics offers a portfolio of digital mental health solutions combining video game-based treatments and immersive VR experiences. The core products include EndeavorRX (prescription video game treatment for pediatric ADHD) and EndeavorOTC (over-the-counter digital therapeutic for adult ADHD), which use adaptive algorithms to target attention and impulse control networks. The Breakthrough platform provides a mental fitness training solution built around Bloom, an immersive VR meditation experience, supplemented by apps like Happy Happy (attention training), Travel-to (cognitive enhancement through virtual travel), and Sights & Sounds (curiosity activation). All VR-based products run on Meta Quest headsets and are designed for clinical, employer, and consumer use.

Differentiator

Problem solved

Functional benefit

Brands

• EndeavorRX: The only doctor-prescribed video game treatment for kids with ADHD, developed by Akili's neuroscientists and game designers. Clinically proven to improve attention and focus.
• EndeavorOTC
• Breakthrough
• Bloom

Products and services

• EndeavorRX The only FDA 510(k)-cleared prescription video game treatment for children with ADHD. Clinically proven to improve attention and focus through engaging missions with real-time adaptive difficulty.
• EndeavorOTC The only FDA-authorized digital therapeutic for ADHD available without a prescription, targeting adults. Designed for over-the-counter use, it targets the same brain networks as EndeavorRX with real-time adaptive difficulty.
• Breakthrough

Quantifiable outcome

• 44.2% of participants achieved clinically meaningful attention improvements in GAMES Study
• +7 more outcomes

Named customers5 records

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability1 record

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• MetacoreTechnology or Integration · 15 September 2025Virtual Therapeutics uses Meta Quest headsets for their VR therapy solution, creating an accessible and cost-effective mental healthcare delivery platform. This partnership addresses key barriers like cost and social stigma while leveraging Meta's VR hardware ecosystem.
• Akili InteractivecoreStrategic or Co-development Partner · 26 August 2024Virtual Therapeutics acquired Akili Interactive for $34 million, combining two digital therapeutics companies to form a diversified, leading digital health company. The merger adds EndeavorRX (prescription) and EndeavorOTC (OTC) ADHD treatments to Virtual Therapeutics' portfolio.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Talkspace: Talkspace provides online therapy and psychiatry services to consumers, enterprises, and health plans. While its core is live therapy rather than VR-based DTx, it competes for the same employer-sponsored mental health budget that Virtual Therapeutics targets through Breakthrough enterprise licensing.
• Lyra Health: Lyra Health is a leading mental health benefits platform connecting employees to therapy, coaching, and digital self-care. It offers overlapping digital mental wellness capabilities within a broader care navigation and live therapy offering, competing for employer Breakthrough deals at the benefits-platform layer.
• Spring Health: Spring Health is a comprehensive mental health benefits provider combining therapy, coaching, and digital tools for employers. It competes with Virtual Therapeutics' enterprise Breakthrough sales motion as a broader mental health platform rather than a focused DTx or VR solution.
• BetterHelp: BetterHelp is the largest online therapy platform, offering subscription-based counseling to consumers and via employer partnerships. While not a DTx, it competes for the same consumer mental health wallet share that EndeavorOTC targets, including employer EAP integrations.
• Cerebral: Cerebral offers telehealth mental health services including medication management and counseling for anxiety, depression, and ADHD. It directly overlaps with Virtual Therapeutics' ADHD focus (EndeavorOTC/Rx) but addresses treatment via clinician-prescribed medication rather than digital therapeutics.

Direct peers

• Calm: Calm is a leading mental wellness and meditation app serving consumers, employers (Calm Business), and health plans. Its enterprise mental wellness and sleep offerings directly compete with Virtual Therapeutics' Bloom VR meditation and Breakthrough mental fitness platform for employer mental health benefit dollars.
• Happify Health: Happify Health delivers digital mental health interventions and therapeutic solutions for anxiety, depression, and chronic conditions. It overlaps with Virtual Therapeutics' Breakthrough and Bloom VR mental fitness products in serving health plans, employers, and consumers with evidence-based mental health apps.
• Headspace Health: Headspace Health offers evidence-based mental wellness and therapy services (Headspace, Ginger), serving employers, health plans, and consumers. It directly competes with Virtual Therapeutics' Breakthrough and Bloom products in the employer-sponsored mental fitness category with similar subscription-based enterprise sales motion.
• Big Health: Big Health develops FDA-cleared digital therapeutics for insomnia (Sleepio) and anxiety (Daylight), making it the closest direct peer to Virtual Therapeutics' prescription DTx model. Both target mental health conditions through clinically validated, software-delivered interventions sold to consumers, employers, and health systems.

Emerging players

• Woebot Health: Woebot Health develops AI-powered conversational mental health chatbots and digital therapeutic tools. It competes at the intersection of mental health and digital therapeutics but focuses on chat-based delivery rather than VR, making it an emerging partial overlap rather than a direct competitor.

Market position

Strengths5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/virtualtherapeutics

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Virtual Therapeutics